全文获取类型
收费全文 | 4278129篇 |
免费 | 346328篇 |
国内免费 | 15363篇 |
专业分类
耳鼻咽喉 | 58609篇 |
儿科学 | 137930篇 |
妇产科学 | 113224篇 |
基础医学 | 657408篇 |
口腔科学 | 118832篇 |
临床医学 | 388221篇 |
内科学 | 766487篇 |
皮肤病学 | 108499篇 |
神经病学 | 357147篇 |
特种医学 | 167557篇 |
外国民族医学 | 544篇 |
外科学 | 655701篇 |
综合类 | 127946篇 |
现状与发展 | 23篇 |
一般理论 | 2578篇 |
预防医学 | 350936篇 |
眼科学 | 102039篇 |
药学 | 299947篇 |
22篇 | |
中国医学 | 12385篇 |
肿瘤学 | 213785篇 |
出版年
2021年 | 55079篇 |
2020年 | 35871篇 |
2019年 | 59050篇 |
2018年 | 74504篇 |
2017年 | 56710篇 |
2016年 | 62800篇 |
2015年 | 75881篇 |
2014年 | 110327篇 |
2013年 | 176189篇 |
2012年 | 119817篇 |
2011年 | 124804篇 |
2010年 | 125619篇 |
2009年 | 126920篇 |
2008年 | 110583篇 |
2007年 | 117405篇 |
2006年 | 125867篇 |
2005年 | 120545篇 |
2004年 | 122030篇 |
2003年 | 111585篇 |
2002年 | 100756篇 |
2001年 | 163036篇 |
2000年 | 157981篇 |
1999年 | 145091篇 |
1998年 | 71995篇 |
1997年 | 67694篇 |
1996年 | 65436篇 |
1995年 | 60363篇 |
1994年 | 54565篇 |
1993年 | 50514篇 |
1992年 | 104099篇 |
1991年 | 100202篇 |
1990年 | 95799篇 |
1989年 | 93578篇 |
1988年 | 85692篇 |
1987年 | 84205篇 |
1986年 | 79551篇 |
1985年 | 78127篇 |
1984年 | 65351篇 |
1983年 | 57983篇 |
1982年 | 47002篇 |
1981年 | 43844篇 |
1980年 | 41015篇 |
1979年 | 55332篇 |
1978年 | 45152篇 |
1977年 | 40356篇 |
1976年 | 37235篇 |
1975年 | 36871篇 |
1974年 | 40527篇 |
1973年 | 39014篇 |
1972年 | 36349篇 |
排序方式: 共有10000条查询结果,搜索用时 404 毫秒
101.
Joshua J. Bear Heidi E. Kirsch Brian D. Berman Kevin E. Chapman Jason R. Tregellas 《Epileptic Disord》2020,22(3):291-299
Aims. Functional connectivity is providing new insights into the network nature of epilepsy with growing clinical applications. Our objective was to validate a novel magnetoencephalography‐based method to non‐invasively measure the epileptic network. Methods. We retrospectively identified pediatric and adult patients with refractory focal epilepsy who underwent pre‐surgical magnetoencephalography with subsequent intracranial electrographic monitoring. Magnetoencephalography tracings were visually reviewed, and interictal epileptiform discharges (“spikes”) were individually marked. We then evaluated differences in whole‐brain connectivity during brief epochs preceding the spikes and during the spikes using the Network‐Based Statistic to test differences at the network level. Results. In six patients with statistically‐significant network differences, we observed substantial overlap between the spike‐associated networks and electrographically active areas identified during intracranial monitoring (the spike‐associated network was 78% and 83% sensitive for intracranial electroencephalography‐defined regions in the irritative and seizure onset zones, respectively). Conclusion. These findings support the neurobiological validity of the spike‐associated network method. Assessment of spike‐associated networks has the potential to improve surgical planning in epilepsy surgery patients by identifying components of the epileptic network prior to implantation. 相似文献
102.
103.
目的:探讨健脾益肾方对非小细胞肺癌(NSCLC)细胞体外增殖凋亡的作用。方法:人NSCLC细胞系A549分为四组:空白对照组(仅加入细胞培养液)、阴性对照组(加入细胞,不进行中药处理)、实验组(加细胞加中药处理)。荧光定量PCR和Western blot分别检测Survivin、Bcl-2和Caspase-3的mRNA和蛋白表达。MTT检测细胞增殖;流式细胞术检测细胞凋亡。结果:与空白对照组相比,阴性对照组细胞在24、48、72 h的吸光度值明显升高,细胞凋亡率下降,Survivin和Bcl-2 mRNA和蛋白相对表达量上调,Caspase-3 mRNA和蛋白相对表达量下调,组间比较差异有统计学意义(P<0.05);而健脾益肾方处理的实验组24、48、72 h的吸光度值均显著降低,细胞凋亡率显著上升,Survivin和Bcl-2 mRNA和蛋白相对表达量下调,Caspase-3 mRNA和蛋白相对表达量上调,与空白对照组相比差异有统计学意义(P<0.05)。结论:健脾益肾方可通过下调Survivin和Bcl-2、上调Caspase-3表达诱导NSCLC细胞凋亡,并抑制肿瘤细胞的增殖,进而抑制NSCLC的发展。 相似文献
104.
Rupa Narayan MD Traci M. Blonquist MS Ashkan Emadi MD PhD Robert P. Hasserjian MD Meghan Burke BS Christopher Lescinskas BS Donna S. Neuberg ScD Andrew M. Brunner MD Gabriela Hobbs MD Hanno Hock MD PhD Steven L. McAfee MD Yi-Bin Chen MD Eyal Attar MD Timothy A. Graubert MD Christina Bertoli MSN Jenna A. Moran MSN Meghan K. Bergeron MSN Julia E. Foster MSN Aura Y. Ramos BSN Tina T. Som BSN Megan K. Vartanian BSN RN Jennifer L. Story LPN Kristin McGregor MS Molly Macrae BS Tanya Behnan BS Margaret C. Wey PhD Jessica Rae BSN Frederic I. Preffer PhD Patricia Lesho BA Vu H. Duong MD Mason L. Mann BA Karen K. Ballen MD Christine Connolly BS Philip C. Amrein MD Amir T. Fathi MD 《Cancer》2020,126(6):1264-1273
105.
106.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
107.
108.
109.
110.